|
|
|
6/13/2023
|
|
When:
|
Tuesday, June 13th 2:00 pm
|
|
Where:
|
Virtual United States
|
|
Contact:
|
Delaware BioScience Association
info@delawarebio.org
302-635-0445
|
Online registration is closed.
|
|
« Go to Upcoming Event List
|
|
|

Join us virtually on Tuesday, June 13th at 2 pm for a Local Business Solution webinar presented by DArcy Compliance Consulting. This webinar is geared toward start-up pharma and biotech companies. Catherine Arthey, president of DArcy Compliance Consulting will discuss the development of a Quality roadmap and provide an overview of the critical regulatory requirements that must be met for a successful filing. This event is FREE to all Delaware Bio members! In this webinar you will learn: - When is the right time to start your Quality program. - What does Inspection Readiness mean to startup companies. - What are the first steps in building a Clinical Quality program. - How to plan for future growth. - How to be prepared for future submissions. MEET CATHERINE  | CATHERINE ARTHEY PRESIDENT DARCY COMPLIANCE CONSULTING | Catherine Arthey is a seasoned Quality & Compliance professional, having spent over thirty years in the Pharma/Biotech industry including roles at both GSK, Merck and Deloitte before setting up her own consulting business - DArcy Compliance Consulting.
With a focus on Quality for Start-ups, DArcy Compliance Consulting is a leading provider of Quality & Compliance support for Life Science Start-ups as they transition from fledging R&D organizations to successful companies thriving in a regulated environment. With their practical advice, hands-on approach and years of knowledge and experience, Catherine and her team are highly sought after by companies seeking guidance on a variety of quality issues ranging from what SOPs are required, who needs to be trained on what or requirements for working with vendors and vendor audits etc.
DArcy Compliance Consulting is well established as the leading 'Quality & Compliance' service provider for Start-ups navigating the complex world of regulatory requirements. |
|
|
|